Synthesis and Serotonergic Activity of Arylpiperazide Derivatives of Serotonin: Potent Agonists for 5-HT1D Receptors

Journal of Medicinal Chemistry

Volumn 38, Issue 18, 1995, Pages 3602-3607

  Perez, Michel ^a   Fourrier, Catherine ^a   Sigogneau, Isabelle ^a   Pauwels, Petrus J ^a   Palmier, Christiane ^a   John, Gareth W ^a   Valentin, Jean Pierre ^a   Halazy, Serge ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 [[3 (2 AMINOETHYL) 1H INDOL 5 YL]OXY]ACETYL] 4 [(4 SULFONAMIDOPHENYL)PIPERAZIDE]; RIZATRIPTAN; SEROTONIN 1D RECEPTOR; SEROTONIN AGONIST; SUMATRIPTAN; UNCLASSIFIED DRUG; ZOLMITRIPTAN;

ANIMAL TISSUE; ARTICLE; DRUG ACTIVITY; DRUG RECEPTOR BINDING; DRUG SCREENING; DRUG SYNTHESIS; NONHUMAN; RABBIT; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION;

ANIMAL; HUMAN; MALE; MICE; PIPERAZINES; RABBITS; RECEPTORS, SEROTONIN; SAPHENOUS VEIN; SEROTONIN; SEROTONIN AGONISTS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0029154692     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00018a020     Document Type: Article

References (27)

1. Silberstein, S. D. Serotonin (5-HT) and migraine. Headache 1994, 34, 408-417.
2. Feniuk, W.; Humphrey, P. P. A. The development of a highly selective 5-HTi receptor agonist, sumatriptan, for the treatment of migraine. Drug Dev. Res. 1992, 26, 235-240.
3. SCRIP 1994, 1957, 26.
4. Hoyer, D.; Clarke, D. E.; Fozard, J. R.; Hartig, P. R.; Martin, G. R.; Mylecharane, E. J.; Saxena, P. R.; Humphrey, P. P. A. Pharmacol. Rev. 1994, 46, 157-203.
5. Saudou, F.; Hen, R. 5-HT receptor subtype: Molecular and functional diversity. Med Chem Res 1994, 4, 16-84.
6. Hamel, E.; Grégoire, L.; Lau, B. 5-HTi receptors mediating contraction in bovine cerebral arteries: a model for human cerebrovascular “5-HTid, /’ receptors. Eur. J. Phamacol. 1993, 242, 75-82.
7. Kaumann, A. J.; Parsons, A. A.; Brown, A. M. Human arterial constrictor serotonin receptors Cardiovas. Res. 1993, 27, 2094-2103.
8. a serotonin receptor gene expression in trigeminal ganglia: Implications for antimigraine drug development. Proc. Natl. Acad. Sci. U. S. A. 1994, 91, 3666-3669.
9. Peroutka, S. J. Pharmacological differentiation of human 5-HTib and 5-HTid receptors. Biol. Signals 1994, 3, 217-222.
10. Frehel, D.; De Cointet, P.; Badorc, A.; Castet, C.; Courregelongue, J.; Despeyroux, P.; Ducros, D.; Guiraudou, P.; Leger, J. M.; Raufaste, D.; Saint-Blancat, A.; Serradeil-Le Gal, C.; Le Fur, Gérard; Maffrand, J. P. SR 27592 and SR 28734: New potent and specific agonists of 5-HTID receptors. Groupe d’Etude Structure Activité N°XXIII, Annecy, France, 25-28 May 1993.
11. Connor, H. E.; O’Shaughnessy, C. T.; Feniuk, W.; Perren, M. J.; North, P. C.; Oxford, A. W.; Butina, D.; Owen, M.; Humphrey, P. P. A. GR85548: a potent selective agonist for the intracranial vascular 5-HTi receptor. Proc. Br. Pharmacol. Soc. (Jan 5-7, Cambridge) 1993, Abst C107.
12. King, F. D.; Brown, A. M.; Gaster, L. M.; Kaumann, A. J.; Medhurst, A. D.; Parker, S. G.; Parsons, A. A.; Patch, T. L.; Raval, P. (±) 3-amino-6-carboxamido-1, 2, 3, 4-tetrahydrocarba- zole: a conformationnally restricted analogue of 5-carboxami- dotryptamine with selectivity for the serotonin 5-HTm receptor. J. Med. Chem. 1993, 36, 1918-1919.
13. Macor, J. E.; Blank, D. H.; Post, R. J.; Ryan, K. The synthesis of a conformationally restricted analog of the anti-migraine drug sumatriptan. Tetrahedron Lett. 1992, 33, 8011-8014.
14. Lee, W. S.; Moskowitz, M. A. Brain Res. 1993, 626, 303-305.
15. Castro, J. L.; Baker, R.; Guiblin, A. R.; Hobbs, S. C.; Jenkins, M. R.; Russel, M. G. N.; Beer, M. S.; Stanton, J. A.; Scholey, K.; Hargreaves, R. J.; Graham, M. I.; Matassa, V. G. Synthesis and biological activity of 3-[2-(dimethylamino) ethyl]-5-[(1, l-dioxo- 5-methyl-1, 2, 5-thiadiazolidin-2-yl)-methyl]-1-indole and analogues: Agonists for the 5-HTid receptor J. Med. Chem. 1994, 37, 3023-3032.
16. Chen, C. Improved fisher indole reaction for the preparation of N, N-dimethyltryptamines: synthesis of L-695, - 894, a potent 5-HTm receptor agonist J. Org. Cham. 1994, 59, 3738-3741.
17. Castro, J. L.; Matassa, V. G.; Broughton, H. B.; Mosley, R. T.; Street, L. J.; Baker, R. Synthesis, biological activity and electrostatic properties of 3-[2-(dimethylamino)- ethyl]-5-[(3-amino-1, 2, 4-thiadiazol-5-yl) methyl]-lH-indoie, a novel 5-HTid receptor agonist. Bioorg. Med. Chem. Lett. 1993, 3, 993-997.
18. Street, L. J.; Baker, R.; Castro, J. L.; Chambers, M. S.; Guiblin, A. R.; Hobbs, S. C.; Matassa, V. G.; Reeve, A. J.; Beer, M. S.; Middlemiss, D. N.; Noble, A. J.; Stanton, J. A.; Scholey, K.; Hargreaves, R. J. Synthesis and serotonergic activity of 5-(oxadiazolyl) tryptamines: Potent agonists for 5-HTm receptors. J. Med. Chem. 1993, 36, 1529-1538.
19. Macor, J. E.; Blank, D. H.; Fox, C. B.; Lebel, L. A.; Newman, M. E.; Post, R. J.; Ryan, K.; Schmidt, A. W.; Schultz, D. W.; Koe B. K. 5-[(3-nitropyrid-2-yl) amino]indoles: novel serotonin agonists with selectivity for the 5-HTm receptor. Variation of the C3 substituent on the indole template leads to increased 5-HTm receptor selectivity. J. Med. Chem. 1994, 37, 2509-2512.
20. Boulenguez, P.; Chauveau, J.; Segu, L.; Morel, A.; Delaage, M.; Lanoir, J. Pharmacological characterization of serotonin-o- carboxymethyl-glycyl-tyrosinamide, a new selective indolic ligand for 5-hydroxytryptamine (5-HT) m and 5-HTm binding sites. J. Pharmacol. Exp. Ther. 1991, 259, 1360-1365.
21. Glennon, R. A.; Hong, S.-S.; Dukat, M.; Teitler, M.; Davis K. 5-(nonyloxy) tryptamine: A novel high-affinity 5-HTm, s serotonin receptor agonist. J. Med. Chem. 1994, 37, 2828-2830.
22. Perez, M.; Pauwels, P.; Palmier, C.; John, G. W.; Valentin, J. P.; Halazy, S. 5-0 carboxymethyl piperazide derivatives of serotonin: a new class of potent and selective 5-HTm receptor agonists Bioorg. Med. Chem. Lett. 1995, in press.
23. 1D/J receptors mediating inhibition of cAMP in permanently transfected CHO-Ki cells: pharmacological characterisation of agonists, partial agonists and antagonists. Cell. Pharmacol. 1995, 2, 49-57.
24. Pauwels, P. J.; Van Gompel, P.; Leysen, J. E. Activity of 5-HT receptor agonists, partial agonists and antagonists at cloned human 5-HTu receptors that are negatively coupled to adenylate cyclase in permanently transfected HeLa-cells. Biochem. Pharmacol. 1993, 45, 375-383.
25. Martin, G. R.; McLennan, S. J. Analysis of the 5-HT receptor in rabbit saphenous vein Exemplifies the problems of using exclusion criteria for receptor. Naunyn-Schmiedeb. Arch. Pharmacol. 1990, 342, 111-119.
26. Valentin, J.-P.; Bonnafous, R.; Jorand, C.; Perez, M.; Halazy, S.; Colpaert, F. C.; John, G. W. Influence of endothelium and nitric oxide on the contractile responses evoked by 5-HTm receptor agonists in the rabbit isolated saphenous vein. Pharmacol. Res. 1995, 31, 156.
27. Marquardt, D. W. An algorithm for least squares estimation of nonlinear parameters. J. Soc. Indust. Appi. Math. 1963, 11, 431.